David E. Lazar - Net Worth and Insider Trading
David E. Lazar Net Worth
The estimated net worth of David E. Lazar is at least $0 dollars as of 2024-11-07. David E. Lazar is the CEO, 10% Owner of Titan Pharmaceuticals Inc and owns about 0 shares of Titan Pharmaceuticals Inc (TTNP) stock worth over $0. Details can be seen in David E. Lazar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David E. Lazar has not made any transactions after 2023-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David E. Lazar
David E. Lazar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David E. Lazar owns 1 companies in total, including Titan Pharmaceuticals Inc (TTNP) .
Click here to see the complete history of David E. Lazar’s form 4 insider trades.
Insider Ownership Summary of David E. Lazar
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TTNP | Titan Pharmaceuticals Inc | 2023-06-21 | director & 10 percent owner & Chief Executive Officer |
David E. Lazar Latest Holdings Summary
David E. Lazar currently owns a total of 1 stock. David E. Lazar owns 0 shares of Titan Pharmaceuticals Inc (TTNP) as of June 21, 2023, with a value of $0.
Latest Holdings of David E. Lazar
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TTNP | Titan Pharmaceuticals Inc | 2023-06-21 | 0 | 4.10 | 0 |
Holding Weightings of David E. Lazar
David E. Lazar Form 4 Trading Tracker
According to the SEC Form 4 filings, David E. Lazar has made a total of 4 transactions in Titan Pharmaceuticals Inc (TTNP) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Titan Pharmaceuticals Inc is the sale of 187,398 shares on June 21, 2023, which brought David E. Lazar around $5 Million.
Insider Trading History of David E. Lazar
- 1
David E. Lazar Trading Performance
GuruFocus tracks the stock performance after each of David E. Lazar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David E. Lazar is 2.34%. GuruFocus also compares David E. Lazar's trading performance to market benchmark return within the same time period. The performance of stocks bought by David E. Lazar within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David E. Lazar's insider trading performs compared to the benchmark.
Performance of David E. Lazar
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 26.67 | | | | | |
| Relative Return to S&P 500(%) | 23.34 | | | | | |
David E. Lazar Ownership Network
Ownership Network List of David E. Lazar
Ownership Network Relation of David E. Lazar
David E. Lazar Owned Company Details
What does Titan Pharmaceuticals Inc do?
Who are the key executives at Titan Pharmaceuticals Inc?
David E. Lazar is the director & 10 percent owner & Chief Executive Officer of Titan Pharmaceuticals Inc. Other key executives at Titan Pharmaceuticals Inc include 10 percent owner Seow Gim Shen , 10 percent owner Sire Group Ltd. , and director & President and COO Katherine Beebe .
Titan Pharmaceuticals Inc (TTNP) Insider Trades Summary
Over the past 18 months, David E. Lazar made 2 insider transaction in Titan Pharmaceuticals Inc (TTNP) with a net sale of 7,495,936.
In summary, during the past 3 months, insiders sold 0 shares of Titan Pharmaceuticals Inc (TTNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 374,797 shares of Titan Pharmaceuticals Inc (TTNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 374,797 shares.
Titan Pharmaceuticals Inc (TTNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Titan Pharmaceuticals Inc Insider Transactions
David E. Lazar Mailing Address
Above is the net worth, insider trading, and ownership report for David E. Lazar. You might contact David E. Lazar via mailing address: Villa 1, 14-43rd Street, Jumeirah 2, Dubai C0 00000.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
